Jardiance (Empagliflozin) Updates for 2026: Uses, Risks, and What’s New
Introduction to Jardiance (Empagliflozin) Jardiance, known generically as empagliflozin, is a medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. This pharmacological classification indicates its mechanism of action, which is primarily to lower blood sugar levels through inhibition of glucose reabsorption in the kidneys. As a result, Jardiance facilitates the excretion of excess glucose via … Read more